Delivery Order SPE2DB22D3401-SPE2DB24FT0SB

Award Date 11/24/23
Potential Completion Date 11/27/23
Potential Value $11K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Varenicline 0.5 mg tablets to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $5,379.72 and an ultimate completion date of February 8, 2024, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award is for the delivery of Varenicline 1 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, which is a major component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $9,705.74 and an ultimate completion date of September 19, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract was awarded on...
This contract award is for the delivery of Varenicline 1 mg tablets (56 count bottles) to the Defense Logistics Agency (DLA). The $3,297.82 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
This federal contract award by the Defense Logistics Agency (DLA) is for the delivery of 56 tablets of the pharmaceutical product Varenicline 1 mg. The contract, valued at $10,083.01, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm-Fixed-Price Delivery Order with an ultimate completion date of April 30, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Varenicline 1 mg tablets, a pharmaceutical product, with a ceiling value of $5,931.86 and a completion date of November 2, 2023. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) is a Delivery Order valued at $4,660.60 issued by the Defense Logistics Agency (DLA) for the procurement of Varenicline 1 mg tablets. The contract has a completion date of February 8, 2024 and is a Firm Fixed Price type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary...
The Department of Defense's Defense Logistics Agency (DLA) awarded a $3,061.08 firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 56 tablets of the drug varenicline 1 mg. This order was placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $5,998.79 for the supply of 4,564,490,577 units of the pharmaceutical product Varenicline 1 mg Tablet 56s. The award was made by the Defense Logistics Agency (DLA) and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,109.88 firm fixed-price delivery order is for the supply of 56 tablets of the medication Varenicline 1 mg. The contract has an ultimate completion date of February 20, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $5,133.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567765918 units of the drug Varenicline 1 mg tablets in 56-count packages. The contract has an ultimate completion date of April 2, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds a...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB24FT0SB
    Delivery Order

This federal contract award is for the delivery of Varenicline 0.5 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $10,760.91, was made to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has an ultimate completion date of November 27, 2023, and is a Firm Fixed Price Delivery Order. There is no set-aside designation mentioned in the information provided. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veterans' healthcare programs globally. This specific award appears to be a delivery order under that larger IDC.

Generated 5/12/25, 10:30 AM